The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
1. Discuss the evidence for the use of SGLT2 inhibitors in the management of heart failure
2. Review the clinical evidence for the use of soluble guanylate cyclase stimulator in the management of heart failure
3. Describe therapies on the horizon in clinical trial for heart failure